Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
SchmidtEPOverdierKHSunXLinLLiuXYangYet al
Pharmacol Rep 68(2):329337 Chen J, Mei A, Liu X, Braunstein Z, Wei Y, Wang B et al (2022) Glucagon-Like Peptide-1 receptor regulates macrophage migration in monosodium Urate-Induced peritoneal inflammation
In Vitro Cell
It attenuates ischemia/reperfusion injury by suppressing NLRP3 inflammasome and apoptosis, mitigating ferroptosis via Nur77-IDH1 signaling (Zhang et al., 2020
Derm professional we know what to expect, but this skin transformation blew our minds
